Index of artpub/2018/pmc_29600394/

Blauvelt, Andrew
Correction to : Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
2018
https://ddd.uab.cat/record/190768
[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]1=Blauvelt,_Andrew2022-06-29 13:33 17  
[ ]2=Correction_to__Efficacy_and_Safety_of...2022-06-29 13:33 211  
[ ]3=20182022-06-29 13:33 5  
[ ]4=1907682022-06-29 13:33 34  
[TXT]pmc_29600394.dirinfo2024-10-02 04:41 341  
[ ]pmc_29600394.du2024-10-02 04:41 32  
[TXT]pmc_29600394.dupdirs2024-10-02 04:41 0  
[TXT]pmc_29600394.dupfiles2024-10-02 04:41 0  
[TXT]pmc_29600394.errors2024-10-02 04:41 0  
[IMG]pmc_29600394.gif2024-10-02 04:41 4.7K 
[IMG]pmc_29600394.ico2024-10-02 04:41 12K 
[TXT]pmc_29600394.info2024-10-02 04:41 35K 
[TXT]pmc_29600394.md52024-10-02 04:41 51  
[ ]pmc_29600394.pdf2024-10-02 04:41 320K 
[TXT]pmc_29600394.sha12024-10-02 04:41 59  
[TXT]pmc_29600394.sha2562024-10-02 04:41 83  
[TXT]pmc_29600394.stats2024-10-02 04:41 246  
[TXT]pmc_29600394.txt2024-10-02 04:41 3.5K